Apoptosis regulation and spontaneous apoptosis index of testicular germ cell tumors are associated with differentiation and resistance to systemic treatment

Anticancer Research

Volumn 28, Issue 3 A, 2008, Pages 1641-1649

  Mándoky, László ^a   Szende, Béla ^b   Géczi, Lajos ^a   Bodrogi, István ^a   Kásler, Miklós ^a   Bak, Mihály ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Apoptosis; Chemoresistance; Differentiation; Germ cell testicular tumor; p21; p53

Indexed keywords

CISPLATIN; PROTEIN P21; PROTEIN P53;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL DIFFERENTIATION; CHEMOSENSITIVITY; CHORIOCARCINOMA; CONTROLLED STUDY; EMBRYONAL CARCINOMA; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST; TERATOMA;

ADOLESCENT; ADULT; APOPTOSIS; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 45949094945     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Pottern ML, Brown M and Devesa SS: Epidemiology and pathogenesis of testicular cancer. In: Testicular and Penile Cancer. Ernsthoff MS, Heaney JA and Peschel RE (eds). Oxford, Blackwell Science, pp. 2-10, 1998.
2. Einhorn LH: Curing metastatic testicular cancer. Proc Natl Acad Sci USA 9: 4592-4595, 2002.
3. Fizazi K, Tjulandin S, Salvioni R, Germa-Lluch JR, Bouzy J, Ragan D, Bokemeyer C, Gerl A, Flechon A, de Bono JS, Stenning S, Horwich A, Pont J, Albers P, De Giorgi U, Bower M, Bulanov A, Pizzocaro G, Aparicio J, Nichols CR, Theodore C, Hartmann JT, Schmoll HJ, Kaye SB, Culine S, Droz JP and Mahe C: Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy - results from an international study group. J Clin Oncol 19: 2647-2657, 2001.
4. Wozniak K and Blasiak J: Recognition and repair of DNA-cisplatin adducts. Acta Biochim Pol 49: 583-596, 2002.
5. Niedner H, Christen R, Lin X, Kondo A and Howell SB: Identification of genes that mediate sensitivity to cisplatin. Mol Pharmacol 60: 1153-1160, 2001.
6. Braun RE: Every sperm is sacred - or is it? Nat Genet 18: 202-204, 1998.
7. Levine AJ: p53, The cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
8. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849, 1993.
9. Schenkman NS, Sesterhenn IA, Washington L, Tong YA, Weghorst CM, Buzard GS, Srivastava S and Moul JW: Increased p53 protein does not correlate to p53 gene mutations in microdissected human testicular germ cell tumors. J Urol 154: 617-621, 1995.
10. Houldsworth J, Xiao H, Murty VV, Chen W, Ray B, Reuter VE, Bosl GJ and Chaganti RS: Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation. Oncogene 16: 2345-2349, 1998.
11. Kersemaekers AM, Mayer F, Molier M, van Weeren PC, Oosterhuis JW, Bokemeyer C and Looijenga LH: Role of P53 and MDM2 in treatment response of human germ cell tumors. J Clin Oncol 20: 1551-1561, 2002.
12. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995.
13. Polyak K, Waldman T, He TC, Kinzler KW and Vogelstein B: Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 10: 1945-1952, 1996.
14. Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene 18: 1131-1138, 1999.
15. Bartkova J, Thullberg M, Rajpert-De Meyts E, Skakkebaek NE and Bartek J: Cell cycle regulators in testicular cancer: loss of p18INK4C marks progression from carcinoma in situ to invasive germ cell tumours. Int J Cancer 85: 370-375, 2000.
16. Mostofi FK and Sesterhenn IA: Histological typing of testis tumours. In: International Histological Classification of Tumours (2nd edition). Berlin, Springer-Verlag, pp. 7-17, 1998.
17. Javadpour N: The role of biologic tumor markers in testicular cancer. Cancer 45(Suppl): 1755-1761, 1980.
18. Sobin LH and Wittekind C: UICC TNM Classification of Malignant Tumours. New York, Wiley-Liss, pp. 227, 1997.
19. Géczi L, Gomez F, Horvath Z, Bak M, Kisbenedek L and Bodrogi I: Three-year results of the first educational and early detection program for testicular cancer in Hungary. Oncology 60: 228-234, 2001.
20. Fléchon A, Rivoire M, Biron P and Droz JP: Importance of surgery as salvage treatment after high dose chemotherapy failure in germ cell tumors. J Urol 165: 1920-1926, 2001.
21. Eid H, Gulyás M, Géczi L, Bodrogi I, Institoris E and Bak M: Expression of bcl-2 in testicular carcinoma: correlation with tumor progression and MDR1/Pgp. Cancer 83: 331-336, 1998.
22. Print CG and Loveland KL: Germ cell suicide: new insights into apoptosis during spermatogenesis. Bioessays 22: 423-430, 2000.
23. Lane DP: p53 and human cancers. Br Med Bull 50: 582-599, 1994.
24. Eid H, Van der Looij M, Institoris E, Géczi L, Bodrogi I, Oláh E and Bak M: Is p53 expression, detected by immunohisto-chemistry, an important parameter of response to treatment in testis cancer? Anticancer Res 17: 2663-2669, 1997.
25. Waf1/cip1 protein level sensitizes testicular germ cell tumor cells to Fas-mediated apoptosis. Oncogene 23: 4862-4872, 2004.
26. Mayer F, Stoop H, Scheffer GL, Scheper R, Oosterhuis JW, Looijenga LH and Bokemeyer C: Molecular determinants of treatment response in human germ cell tumors. Clin Cancer Res 9: 767-773, 2003.